Application Deadline: June 1, 2026
In many parts of the world, including Saudi Arabia, gaps still exist in understanding how pneumococcal disease affects young children, especially in the post-vaccine era. The Pfizer Research Grant 2026 is designed to address this gap by supporting high-impact surveillance studies focused on pediatric populations.
With funding of up to $400,000 per project, this competitive grant offers institutions in Saudi Arabia the opportunity to generate critical data that can shape future vaccine strategies and public health decisions.
Quick Facts
| Host Country: | Saudi Arabia |
| Funding: | Up to $400,000 |
| Project Duration: | Up to 3 years |
| Program Type: | Competitive Research Grant |
| Deadline: | June 1, 2026 |
| Start Date: | November 2026 |
About the Pfizer Research Grant 2026
The Pfizer Research Grant is part of the company’s global effort to support independent healthcare research that improves patient outcomes. For 2026, the focus is on pediatric pneumococcal disease and serotype distribution in Saudi Arabia.
Despite the widespread use of pneumococcal vaccines, there is still limited country-specific data on how the disease behaves, particularly among children under five. This lack of data makes it difficult to fully assess disease burden and evaluate the long-term impact of vaccination programs.
This grant aims to support research projects that can fill these gaps through structured, data-driven studies.
Research Focus Areas
Applicants are expected to design studies that explore pneumococcal disease epidemiology using surveillance methods. Key research areas include:
- Distribution of pneumococcal serotypes in children under five
- Surveillance of invasive and non-invasive infections
- Genetic evolution of pneumococci following vaccination programs
- Antibiotic resistance patterns in Streptococcus pneumoniae
Projects may use:
- Retrospective data analysis
- Laboratory samples already in storage
- Prospective surveillance studies
The use of modern diagnostic tools, such as PCR or genome sequencing, is encouraged.
Funding & Project Support
Successful applicants can receive:
- Up to $400,000 in total funding
- Coverage for direct and indirect research costs
- Institutional overhead (capped at 28%)
In some exceptional cases, projects requesting more than $400,000 may be considered.
The maximum project duration is three years, allowing sufficient time for data collection, analysis, and publication.
Eligilibity Criteria
This grant is strictly targeted at institutions based in Saudi Arabia.
To qualify:
- The Principal Investigator (PI) must hold an MD, PhD, PharmD, or equivalent
- The PI must be affiliated with an eligible organization
- Only organizations (not individuals) can apply
- Multicenter collaborations are encouraged
Independent medical groups or unaffiliated individuals are not eligible.
Additionally, the applying institution must be legally able to receive funding directly from Pfizer.
You may also like: Internet Society Foundation Research Grant 2026 ($200K–$500K Funding for Global Researchers)
Project Requirements
Applicants must submit a well-structured proposal that includes:
- Clear research objectives
- Study design and methodology
- Statistical analysis plan
- Budget breakdown (in USD)
- Publication and dissemination plan
Priority will be given to projects with strong plans for sharing findings through:
- Academic journals
- Conferences
- Public health platforms
Important Dates
- Application Deadline: June 1, 2026
- Award Notification: September 2026
- Project Start: November 2026
- Project End: October 2029
Late applications will not be considered.
How to Apply
Applications must be submitted through Pfizer’s official grant portal.
Steps:
- Visit the application portal
- Create an account (for new users)
- Start a new research grant application
- Upload your full proposal and required documents
Be sure to select:
- Competitive Grant: Yes
- Program Name: 2026 VAC KSA Pneumococcal Disease in Children RES
Why this Grant matters
What makes this opportunity stand out is its real-world impact.
Rather than funding broad or theoretical studies, this grant focuses on generating country-specific data that can directly influence:
- Vaccine policy decisions
- Public health strategies
- Pediatric disease management
For institutions in Saudi Arabia, this is a chance to contribute to globally relevant research while addressing local healthcare challenges.
For more details, visit Pfizer.
